Cairo – Mubasher: The Egyptian Exchange (EGX) announced that Ibnsina Pharma’s stock witnessed a transaction worth EGP 670.4 million on Thursday.
The deal involved the trading of 69.11 million shares at EGP 9.7 per share, the EGX said in a statement.
The company’s capital reaches EGP 205 million distributed over 820 million shares at a nominal value of EGP 0.25 apiece.
During the first half of 2019, Ibnsina Pharma’s profits rose to EGP 103.19 million, compared to EGP 76.56 million in the year-ago period.
